Alnylam Pharmaceuticals (NASDAQ:ALNY) Receives Outperform Rating from William Blair
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a research note issued on Friday,RTT News reports. ALNY has been the subject of a number of other research reports. JPMorgan Chase & Co. boosted their price target on shares of Alnylam Pharmaceuticals from $272.00 […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at William Blair in a research note issued on Friday,RTT News reports. ALNY has been the subject of a number of other research reports. JPMorgan Chase & Co. boosted their price target on shares of Alnylam Pharmaceuticals from $272.00 […]
